Physician profile
Michael J Moran
NPI 1154380319
$5,245.09
in general payments reported to CMS, 2019-2025
23 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.79 · 2020: $973 · 2021: $260 · 2022: $438 · 2023: $549 · 2024: $1,733 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,824 · Travel and Lodging: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.78 |
| Travel and Lodging | $687.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,718.57 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $1,317.34 | 2020-2025 | Avvigo Guidance System, Rotapro, Mamba |
| Abbott Laboratories | $644.62 | 2019-2025 | Mitraclip, Aveir, Gallant |
| Medtronic, INC. | $394.87 | 2021-2025 | Corevalve Evolut R, Ffrangio, Onyx Frontier |
| Penumbra, INC. | $200.65 | 2023-2025 | Indigo System, Penumbra System, Ruby Coil |
| Shockwave Medical, INC | $166.75 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $137.86 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $101.41 | 2024-2025 | |
| Philips North America LLC | $96.40 | 2021-2025 | Lm Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.84 | 2023-2025 | Jardiance |
| Terumo Medical Corporation | $65.97 | 2025 | Tr Band |
| Cardiva Medical, INC. | $61.45 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Optowire |
| Teleflex LLC | $45.88 | 2023 | Guideliner, Manta |
| E.R. Squibb & Sons, L.L.C. | $39.62 | 2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $39.13 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $34.01 | 2022-2024 | Ecm Patch,Pouch |
| Chiesi USA, INC. | $28.30 | 2024-2025 | Cleviprex, Kengreal |
| Acist Medical Systems, INC. | $21.21 | 2025 | |
| Inspire Medical Systems, INC. | $20.40 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.77 | 2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $13.54 | 2023 | Inpefa |
| Medtronic Vascular, INC. | $13.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.